|

|

|




See Related:
Authors' Articles

Return to
Table of Contents

Author/Article
Information




Author/Article
Information


|

|

|

|

|

Large-Scale
Quarantine Following Biological Terrorism in the United States
Scientific
Examination, Logistic and Legal Limits, and Possible Consequences
Joseph
Barbera, MD; Anthony Macintyre, MD; Larry Gostin, JD, PhD; Tom Inglesby, MD;
Tara O'Toole, MD; Craig DeAtley, PA-C; Kevin Tonat, DrPH, MPH; Marci Layton,
MD
Concern for potential
bioterrorist attacks causing mass casualties has increased recently.
Particular attention has been paid to scenarios in which a biological agent
capable of person-to-person transmission, such as smallpox, is intentionally
released among civilians. Multiple public health interventions are possible
to effect disease containment in this context. One disease control measure
that has been regularly proposed in various settings is the imposition of
large-scale or geographic quarantine on the potentially exposed population.
Although large-scale quarantine has not been implemented in recent US
history, it has been used on a small scale in biological hoaxes, and it has
been invoked in federally sponsored bioterrorism exercises. This article
reviews the scientific principles that are relevant to the likely
effectiveness of quarantine, the logistic barriers to its implementation,
legal issues that a large-scale quarantine raises, and possible adverse
consequences that might result from quarantine action. Imposition of large-scale
quarantine compulsory
sequestration of groups of possibly exposed persons or human confinement
within certain geographic areas to prevent spread of contagious disease should
not be considered a primary public health strategy in most imaginable
circumstances. In the majority of contexts, other less extreme public health
actions are likely to be more effective and create fewer unintended adverse
consequences than quarantine. Actions and areas for future research,
policy development, and response planning efforts are provided.
JAMA.
2001;286:2711-2717
View Full
Text
Author/Article
Information

Author Affiliations: Institute for Crisis and Disaster Management,
George Washington University (Dr Barbera), and Department of Emergency
Medicine, George Washington University Medical Center (Dr Macintyre and Mr
DeAtley), Washington, DC; Center for Law & the Public's Health,
Georgetown University and Johns Hopkins University (Dr Gostin), and Center
for Civilian Biodefense, Johns Hopkins University (Drs Inglesby and O'Toole),
Baltimore, Md; Office of Emergency Preparedness, Department of Health and
Human Services, Rockville, Md (Dr Tonat); and Department of Public Health,
New York, NY (Dr Layton).
Corresponding Author and Reprints: Joseph Barbera, MD, 13814 Oxmoor
Pl, Germantown, MD 20874 (e-mail: jbarbera@seas.gwu.edu;
emdjab@gwumc.edu).
Disclaimer: The opinions and findings in this
article are those of the authors and should not be construed as official
policies or positions of the US Public Health Service or the New York City
Department of Health.
|

|

|